Pediatric Pharmacology and Therapeutics

About Conference

Join us at the 7th International Conference on Pediatric Pharmacology and Therapeutics

We are pleased to invite you to the 7th International Conference on Pediatric Pharmacology and Therapeutics, taking place on April 23–24, 2026, in Toronto, Canada. This distinguished conference focuses on the latest advancements in pediatric drug research and therapeutic practices, bringing together leading experts and professionals dedicated to improving child health through innovative pharmacology.

Conference Theme:
“Advancing Safer and Smarter Medicines for Children: Bridging Innovation and Clinical Care”

Conference Details:

About Pediatric Pharmacology 2026:
This conference highlights cutting-edge developments in pediatric therapeutics, clinical trials, drug safety, and novel treatment approaches. It offers healthcare practitioners, researchers, and industry leaders a valuable platform to exchange knowledge, share best practices, and explore the future of safe and effective medication use in children. Centered on the theme “Advancing Safer and Smarter Medicines for Children: Bridging Innovation and Clinical Care” the event aims to foster collaboration and inspire transformative solutions in pediatric pharmacology.

Call for Participation:
We warmly encourage clinicians, scientists, pharmacists, pediatricians, healthcare professionals, and students to present their latest research, case studies, and innovative therapies. Whether your work involves pharmacokinetics, drug delivery systems, regulatory affairs, or precision medicine—Pediatric Pharmacology 2026 is your opportunity to connect, collaborate, and advance pediatric healthcare.

Join us in Toronto to contribute to safer, more effective treatments for children worldwide.

Register now and be a part of the future of pediatric pharmacology!

Benefits of Attending

Step into the future of pediatric healthcare innovation at the 7th International Conference on Pediatric Pharmacology and Therapeutics—a premier global gathering where leading researchers, clinicians, and industry experts come together to spark transformative ideas.

Over two dynamic days in vibrant Toronto, we’ll explore cutting-edge advancements in pediatric pharmacology, drug safety, clinical therapeutics, and personalized medicine. This conference is your gateway to discovering breakthrough research and practical solutions that address the most pressing challenges in child health—fostering safer and more effective treatments for young patients worldwide.

Join us as we ignite collaboration, inspire innovation, and shape the next frontier in Pediatric pharmacology and therapeutics.

SCOPE AND SIGNIFICANCE

The 7th International Conference on Pediatric Pharmacology and Therapeutics serves as a vital platform for sharing the latest advancements and research in the specialized field of Pediatric drug development, safety, and clinical therapeutics. As children have unique physiological and developmental considerations, this conference focuses on addressing the complexities of Pediatric pharmacology to improve the safety, efficacy, and accessibility of medications for young patients.

The conference covers a broad range of topics including pediatric drug trials, pharmacokinetics and pharmacodynamics in children, personalized medicine, novel drug delivery systems, regulatory challenges, and emerging therapies for pediatric diseases. By bringing together clinicians, researchers, pharmaceutical experts, and policymakers, the event fosters interdisciplinary collaboration essential for advancing pediatric healthcare.

This gathering is significant in driving forward evidence-based approaches and innovative solutions that meet the unmet medical needs of children globally, ultimately improving health outcomes and quality of life for this vulnerable population.

JOBS AND THE ECONOMY

The field of pediatric pharmacology and therapeutics is a growing sector that plays a crucial role in improving child healthcare outcomes while contributing significantly to the global economy. Currently, there is a strong demand for skilled professionals including clinical researchers, pediatric pharmacists, regulatory experts, and pharmaceutical developers who specialize in pediatric medicine.

Looking to the future, advances in personalized medicine, biotechnology, and drug delivery systems are expected to create new jobs and drive economic growth in pharmaceutical industries, healthcare institutions, and research organizations. Investment in pediatric drug development not only enhances treatment options for children but also stimulates innovation, supports high-tech manufacturing, and encourages collaborations between academia and industry—fostering sustainable economic development and improving global health infrastructure.

WHAT TO EXPECT?

At the 7th International Conference on Pediatric Pharmacology and Therapeutics, you can expect an engaging and comprehensive program packed with the latest research findings, clinical advancements, and innovative therapeutic strategies tailored for pediatric care. Over two days, attendees will benefit from:

• Insightful keynote presentations by leading experts in pediatric pharmacology and drug development
• In-depth sessions covering drug safety, pharmacokinetics, novel therapies, and personalized medicine
• Interactive panel discussions addressing regulatory challenges and ethical considerations in pediatric drug trials
• Opportunities to present your research through oral and poster presentations
• Networking events to connect with fellow researchers, clinicians, industry leaders, and policymakers
• Exhibitions showcasing cutting-edge pharmaceutical technologies and pediatric healthcare solutions.

TARGET AUDIENCE

The 7th International Conference on Pediatric Pharmacology and Therapeutics is tailored for a broad range of professionals involved in pediatric healthcare, pharmaceutical research, and drug development, including:

• Pediatricians and Clinical Pharmacologists
• Pharmaceutical Researchers and Scientists
• Pharmacists and Pharmacy Technicians
• Healthcare Providers in Pediatric Care
• Regulatory Affairs Specialists and Policy Makers
• Academic Scholars and University Faculty
• Biotechnology and Medical Device Innovators
• Graduate and Postgraduate Students
• Representatives from Health Organizations, NGOs, and Government Agencies
• Industry Professionals from Pharmaceutical and Biotech Companies

Sessions/Tracks

Track 1: Innovations in Pediatric Pharmacology and Drug Development

Innovations in Pediatric Pharmacology and Drug Development focuses on the evolving landscape of medication design and testing specifically tailored for children. Unlike adults, pediatric patients require specialized drug formulations, dosing strategies, and safety considerations due to differences in physiology, metabolism, and developmental stages. This session highlights the latest advancements in age-appropriate drug delivery systems, personalized dosing models, and ethically designed clinical trials for pediatric populations. It also examines how emerging technologies—such as artificial intelligence, pharmacogenomics, and digital health tools—are transforming the way drugs are discovered, tested, and prescribed for young patients. The goal is to improve treatment outcomes, reduce adverse effects, and ensure that every child receives safe and effective medication tailored to their unique needs.

Track 2: Trends in General Pediatrics and Adolescent Medicine

Trends in General Pediatrics and Adolescent Medicine focus on the evolving healthcare needs of children and adolescents, addressing both traditional concerns and emerging challenges. This area emphasizes comprehensive care that supports physical, mental, and social development through all stages of childhood and adolescence.

Mental Health and Behavioral Disorders
There is growing awareness of mental health issues such as anxiety, depression, and behavioral disorders in young patients. Early identification and integrated care models are becoming essential components of pediatric practice.

Lifestyle-Related Health Challenges
With increasing rates of childhood obesity, diabetes, and related conditions, prevention and management strategies that involve family education and community engagement are key priorities.

Developmental Monitoring and Growth
Regular screening for developmental delays and growth abnormalities allows timely intervention, ensuring optimal child health outcomes.

Adolescent-Specific Health Issues
Care for adolescents includes addressing sexual health, substance use, eating disorders, and the important transition from pediatric to adult healthcare services. Overall, this field is shifting towards a more holistic, preventive, and patient-focussed approach, aiming to improve long-term health and well-being for children and adolescents.

Track 3: Advances in Pediatric Infectious Diseases and Immunization

Advances in Pediatric Infectious Diseases and Immunization cover the latest developments in preventing, diagnosing, and treating infections in children. With infectious diseases remaining a leading cause of morbidity and mortality worldwide, this field is rapidly evolving thanks to new vaccines, improved diagnostic tools, and innovative treatment strategies.

Vaccine Development and Immunization Strategies
Ongoing research is driving the creation of new vaccines targeting pediatric infections, including emerging viruses and antibiotic-resistant bacteria. Immunization programs are being optimized for broader coverage and better compliance globally.

Improved Diagnostic Techniques
Advances in molecular diagnostics and point-of-care testing enable faster and more accurate identification of infectious agents, leading to timely and appropriate treatments.

Antimicrobial Stewardship and Resistance
Efforts to combat antibiotic resistance include rational use of antimicrobials and development of novel therapies to ensure effective treatment options remain available for pediatric patients.

Emerging Infectious Threats
The field is also focused on monitoring and responding to new and re-emerging infectious diseases, adapting immunization and treatment protocols to protect vulnerable populations. These advances collectively enhance the ability to control infectious diseases in children, reduce complications, and improve long-term health outcomes.

Track 4: Future Directions in Pediatric Allergy, Immunology, and Rheumatology

Future Directions in Pediatric Allergy, Immunology, and Rheumatology focus on emerging research and innovative treatments aimed at improving diagnosis, management, and outcomes for children affected by allergic, immune, and rheumatic conditions. This rapidly evolving field integrates advances in biology, genetics, and therapeutics to address complex pediatric disorders.

Personalized Medicine and Biomarkers
The development of biomarkers and genetic profiling is enabling more precise diagnosis and individualized treatment plans, reducing trial-and-error approaches in managing allergies and autoimmune diseases.

Novel Therapeutics and Biologics
New biologic agents and immune-modulating therapies are revolutionizing treatment, offering targeted options that improve efficacy and reduce side effects in conditions like asthma, juvenile arthritis, and immunodeficiencies.

Early Diagnosis and Preventive Strategies
Focus is shifting towards early detection through improved screening tools and interventions designed to prevent disease progression and improve quality of life from an early age.

Integration of Multidisciplinary Care
Future care models emphasize coordinated approaches combining immunology, rheumatology, and allergy specialists to deliver comprehensive management for complex cases. These directions promise to enhance outcomes for pediatric patients by leveraging cutting-edge science and fostering holistic, personalized care.

Track 5:  Pediatric Transplantation and Next-Gen Infection Control

Pediatric Transplantation and Next-Gen Infection Control focuses on the latest advancements in organ and tissue transplantation for children, alongside innovative strategies to prevent and manage infections—a critical challenge in immunocompromised pediatric patients. This field aims to improve transplant success rates and long-term outcomes through enhanced surgical techniques, tailored immunosuppressive therapies, and cutting-edge infection control measures. Emerging technologies such as precision medicine, advanced diagnostics, and real-time infection monitoring are transforming care by enabling early detection and personalized treatment of infections. Together, these advances are helping to reduce complications, improve graft survival, and enhance the overall quality of life for pediatric transplant recipients.

Track 6: Emerging Therapies for Hepatic Disorders in Children

Emerging Therapies for Hepatic Disorders in Children focus on the latest advancements in diagnosing and treating liver diseases that affect pediatric patients. With a growing understanding of the genetic and molecular basis of many hepatic conditions, novel therapeutic approaches are being developed to target the underlying causes rather than just managing symptoms. These include gene therapies, regenerative medicine, and targeted pharmacological treatments that aim to repair liver damage, improve function, and prevent disease progression. Additionally, non-invasive diagnostic tools and biomarkers are enhancing early detection and monitoring of liver health in children. Together, these emerging therapies promise to transform the outlook for young patients with hepatic disorders, offering hope for more effective and less invasive treatments in the future.

Track 7: Pediatric Emergency Medicine and Surgical Breakthroughs

Pediatric Emergency Medicine and Surgical Breakthroughs highlight the latest advancements in the rapid diagnosis, treatment, and surgical care of acute conditions in children. Innovations in emergency medicine include improved protocols, point-of-care diagnostics, and minimally invasive interventions that enable faster, safer, and more effective responses to critical pediatric emergencies. Surgical breakthroughs focus on the development of less invasive techniques, such as laparoscopic and robotic-assisted surgery, which reduce recovery times and improve outcomes. Together, these advancements are transforming pediatric emergency and surgical care by enhancing precision, reducing risks, and improving survival and quality of life for young patients facing urgent medical conditions.

Track 8: Cardiovascular Innovations in Pediatric Cardiology

Cardiovascular Innovations in Pediatric Cardiology focus on the latest technological and therapeutic advances aimed at diagnosing and treating heart diseases in children. This includes the development of minimally invasive catheter-based procedures, advanced imaging techniques, and wearable monitoring devices that allow for earlier detection and precise management of congenital and acquired heart conditions. Innovations in surgical methods and personalized medicine are improving outcomes for complex cardiac cases, while new pharmacological therapies are enhancing the treatment of heart failure, arrhythmias, and other cardiovascular disorders in pediatric patients. These cutting-edge developments are transforming pediatric cardiology by increasing survival rates, reducing complications, and improving long-term heart health for children.

Track 9: Neurodevelopmental Disorders: Diagnosis to Digital Therapies

Neurodevelopmental Disorders: Diagnosis to Digital Therapies explores the evolving landscape of identifying and managing conditions such as autism spectrum disorder, ADHD, and intellectual disabilities in children. Advances in early and accurate diagnosis through genetic testing, neuroimaging, and behavioral assessments are enabling timely interventions. Alongside traditional therapies, digital health innovations—including virtual reality, mobile apps, and AI-driven cognitive training—are emerging as effective tools to support learning, communication, and behavioral improvements. These digital therapies offer personalized, accessible, and engaging treatment options that complement conventional care, ultimately enhancing outcomes and quality of life for children with neurodevelopmental disorders.

Track 10: Pediatric Gastroenterology, Hepatology, and Nutritional Advances

Pediatric Gastroenterology, Hepatology, and Nutritional Advances focus on the latest developments in diagnosing and treating digestive, liver, and nutritional disorders in children. Innovations include improved diagnostic tools such as advanced endoscopy and non-invasive imaging, allowing for earlier and more precise detection of gastrointestinal and hepatic conditions. In nutrition, new research is shaping tailored dietary interventions and therapeutic nutrition strategies to support growth, manage food allergies, and treat malabsorption syndromes. Emerging treatments also target chronic liver diseases and inflammatory bowel conditions, enhancing long-term health outcomes. Together, these advances are improving the quality of care and life for pediatric patients facing complex digestive and nutritional challenges.

Track 11: Genomics and Imaging in Pediatric Diagnostics

Genomics and imaging play complementary roles in pediatric diagnostics by enabling early, accurate identification of diseases. Genomics analyzes a child’s DNA to detect genetic disorders, inherited conditions, or mutations, helping to explain developmental delays, congenital anomalies, and inform personalized treatment plans. Imaging techniques such as X-rays, MRI, ultrasound, and CT scans provide detailed views of internal organs and structures, aiding in the diagnosis of injuries, infections, and abnormalities, as well as monitoring disease progression. Together, these tools enhance diagnostic precision and support better-informed medical decisions in pediatric care.

Track 12: Next-Generation Therapies in Pediatric Hematology and Oncology

Generation therapies are transforming treatment in pediatric hematology and oncology by offering more targeted, effective, and potentially curative options. Gene therapy corrects or replaces faulty genes, showing promise in treating inherited blood disorders like sickle cell disease and thalassemia. Immunotherapy, including CAR T-cell therapy and checkpoint inhibitors, harnesses the child’s immune system to recognize and destroy cancer cells, especially effective in certain leukemias. Targeted therapy uses drugs aimed at specific genetic mutations in cancer cells, reducing harm to healthy tissues and improving outcomes. Stem cell and bone marrow transplants are used to restore healthy blood cell production after high-dose treatments, particularly in cases of leukemia, lymphoma, and severe genetic conditions. Together, these advanced therapies are revolutionizing pediatric care by improving survival rates and quality of life.

Track 13:  Probiotics and Functional Nutrition in Early Childhood

Probiotics and functional nutrition play a vital role in supporting growth, immunity, and overall health during early childhood. Probiotics, which are beneficial live microorganisms, help maintain a healthy gut microbiome, improve digestion, and reduce the risk of infections and allergic conditions. They are particularly useful in managing diarrhea, colic, and antibiotic-associated gastrointestinal issues. Functional nutrition focuses on using nutrient-dense foods to support a child’s unique developmental needs, promoting brain development, immune function, and metabolic health. Together, probiotics and functional nutrition form a foundation for lifelong wellness by supporting balanced growth and preventing nutrition-related disorders early in life.

Track 14: Pediatric Mental Health and Behavioral Science Trends

Pediatric mental health and behavioral science trends are increasingly emphasizing early intervention, holistic wellness, and the use of innovative digital tools to support children’s emotional well?being. There’s growing focus on screening for anxiety, depression, and ADHD in younger age groups and integrating social-emotional learning (SEL) into school curricula to build resilience. Behavioral science approaches now include parent coaching, trauma-informed care, and mindfulness practices tailored for children. Digital technologies—including mental health apps, teletherapy platforms, and virtual reality—are being used more widely to enhance access to care, especially in underserved areas. Collectively, these trends reflect a shift toward proactive, personalized, and accessible support systems aimed at fostering healthy development and preventing more serious mental health issues over the lifespan.

Track 15: Technology-Driven Approaches to Pediatric Diabetes Management

Advancements in technology have significantly improved the management of diabetes in children, offering greater control, safety, and quality of life.

• Continuous Glucose Monitoring (CGM): CGM devices track blood glucose levels in real-time, alerting children and caregivers to high or low blood sugar, which helps prevent emergencies and allows for more precise insulin dosing.
• Insulin Pumps and Smart Pens: These devices deliver insulin more accurately and flexibly than traditional injections, often integrating with CGMs to form automated insulin delivery systems (also known as artificial pancreas systems).
• Mobile Apps and Digital Platforms: Diabetes management apps help with tracking meals, insulin doses, physical activity, and glucose trends, empowering kids and families to make informed decisions.
• Telemedicine and Remote Monitoring: Virtual care allows regular follow-ups and data sharing with healthcare providers, improving access and enabling timely adjustments in treatment.

Together, these technology-driven tools are transforming pediatric diabetes care by enhancing self-management, reducing complications, and improving long-term outcomes.

Market Analysis

Diseases in children—ranging from acute respiratory, ocular, and gastrointestinal infections to chronic conditions such as asthma and persistent diarrhea—remain highly prevalent worldwide. These illnesses not only affect children's health and development but also place significant financial and emotional strain on families. Modern lifestyle changes and environmental factors have further contributed to the rise in pediatric illnesses, increasing the demand for effective and affordable therapeutic solutions.

Currently, the global pediatric healthcare market is witnessing steady growth, reflecting increased parental awareness and rising healthcare needs. From $66 billion in 2010, the market saw substantial expansion and is projected to continue growing, with recent forecasts indicating a CAGR of 4.97% between 2017 and 2021. In parallel, the prevalence of chronic diseases among children has surged at a rate of 7.2%, reinforcing the critical role of pediatric healthcare services and pharmacological innovation.

This growth has attracted significant investment from pharmaceutical companies, biotech firms, and government bodies. Leading industry players such as Pfizer, GlaxoSmithKline, Sanofi, Johnson & Johnson, Gilead Sciences, and Abbott Laboratories, among others, are actively investing in research and development of pediatric drugs and treatments. However, in many developing countries, the sector still faces challenges including limited access, financial constraints, and low public awareness. To address these disparities, there is a growing need for international collaboration, awareness campaigns, public-private partnerships, and targeted funding from global stakeholders.

Looking ahead, the future of pediatric pharmacology lies in personalized medicine, pediatric-specific drug formulations, gene-based therapies, and ethical pediatric clinical trials. With a global focus on reducing infant and child mortality—especially in low-resource settings—there is an urgent call to equip clinicians, researchers, and policymakers with the latest knowledge and tools to address evolving healthcare challenges.

The 7th International Conference on Pediatric Pharmacology and Therapeutics serves as a key platform to advance this mission. Bringing together leading pediatricians, pharmacologists, researchers, industry experts, and global health professionals, the conference will facilitate the exchange of ideas, showcase innovative solutions, and inspire collaborative strategies aimed at shaping the future of pediatric healthcare